PCRX Past Earnings image   This PCRX past earnings page last updated 8/5/2022
PCRX Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/3/20220.510
Q1 20225/4/20220.640
Q4 20212/24/20220.970
Q3 202111/3/20210.720
Q2 20218/3/20210.770
Q1 20215/4/20210.530
Q4 20202/25/20210.870
Q3 202010/29/20200.680
Q2 20208/6/20200.120
Q1 20205/7/20200.530
Q4 20192/20/20200.560
Q3 201911/7/20190.480
Q2 20198/8/20190.410
Q1 20195/2/20190.220
Q4 20182/28/20190.47
Q3 201811/1/20180.31
Q2 20188/2/20180.24
Q1 20185/3/20180.02
Q4 20172/28/20180.38
Q3 201711/8/20170.11
Q2 20178/2/2017-0.11
Q1 20175/4/2017-0.19
Q4 20163/1/20170.09
Q3 201611/2/20160.2
Q2 20168/4/20160.19
Q1 20165/2/20160.14
Q4 20152/25/20160.2
Q3 201510/27/20150.32
Q2 20157/30/20150.2
Q1 20154/30/20150.23
Q4 20142/24/20150.35
Q3 201410/30/20140.14
Q2 20147/31/20140.04
Q1 20145/1/2014-0.34
Q4 20132/25/20140.23
Q3 201310/31/2013-0.44
Q2 20138/6/2013-0.42
Q1 20135/8/2013-0.71
Q4 20123/7/2013-0.5
Q3 201211/1/2012-0.49
Q2 20128/9/2012-0.25
Q1 20125/9/2012-0.47
PCRX Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/3/20220.17B
Q1 20225/4/20220.16B
Q4 20212/24/20220.16B
Q3 202111/3/20210.13B
Q2 20218/3/20210.14B
Q1 20215/4/20210.12B
Q4 20202/25/20210.13B
Q3 202010/29/20200.12B
Q2 20208/6/20200.08B
Q1 20205/7/20200.11B
Q4 20192/20/2020122.42M
Q3 201911/7/20190.10B
Q2 20198/8/20190.10B
Q1 20195/2/20190.09B
Q4 20182/28/201995.11M
Q3 201811/1/201883.45M
Q2 20188/2/201884.11M
Q1 20185/3/201874.61M
Q4 20172/28/201879.08M
Q3 201711/8/201767.33M
Q2 20178/2/201770.93M
Q1 20175/4/201769.28M
Q4 20163/1/201772.90M
Q3 201611/2/201668.36M
Q2 20168/4/201669.64M
Q1 20165/2/201665.47M
Q4 20152/25/201669.32M
Q3 201510/27/201562.21M
Q2 20157/30/201559.15M
Q1 20154/30/201558.32M
Q4 20142/24/201561.79M
Q3 201410/30/201452.00M
Q2 20147/31/201447.20M
Q1 20145/1/201436.70M
Q4 20132/25/201433.60M
Q3 201310/31/201323.26M
Q2 20138/6/201317.14M
Q1 20135/8/201311.60M
Q4 20123/7/201310.45M
Q3 201211/1/20128.49M
Q2 20128/9/201212.34M
Q1 20125/9/20127.80M
Quotes delayed 20 minutes

Email EnvelopeFree PCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Pacira BioSciences (PCRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PCSA Past Earnings
PCVX Past Earnings
PDCO Past Earnings
PDEX Past Earnings
PDSB Past Earnings
PEN Past Earnings
PETV Past Earnings
PFE Past Earnings
PGEN Past Earnings
PGNY Past Earnings

PCRX Past Earnings Q&A

What was the best and worst PCRX past earnings results?
For Pacira BioSciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PCRX past earnings result in our data set was 0.970/share posted in Q4 2021, while the lowest was in Q1 2013 when PCRX posted -0.71/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when PCRX reported 0.17B in revenue, while the quarter with the lowest revenue in our data set was Q1 2012 at 7.80M of revenue.

  Suggested answer: There are 42 PCRX past earnings results in our data set.

On this page we presented the PCRX past earnings date information for Pacira BioSciences. Reviewing that PCRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when PCRX posted adjusted EPS of 0.970/share. Meanwhile the lowest PCRX past earnings result was in Q1 2013, when PCRX posted adjusted EPS of -0.71/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when PCRX reported 0.17B in revenue, while the smallest revenue quarter was Q1 2012 when PCRX reported 7.80M in revenue.

Any self directed investor doing their due diligence on PCRX or any other given stock can benefit from researching all of the Pacira BioSciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Pacira BioSciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PCRX. Thanks for visiting, and the next time you need to research PCRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: NGD Videos, NWLI Historical Stock Prices, Lakeland Bancorp Past Earnings.

 

PCRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.